<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25890183</PMID><DateCompleted><Year>2016</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2015</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE&#x2082; expression.</ArticleTitle><Pagination><StartPage>35</StartPage><MedlinePgn>35</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">35</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-015-0264-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The activation of ERK, p38 and JNK signal cascade in host cells has been demonstrated to up-regulate of enterovirus 71 (EV71)-induced cyclooxygenase-2 (COX-2)/ prostaglandins E2 (PGE&#x2082;) expression which is essential for viral replication. So, we want to know whether a compound can inhibit EV71 infection by suppressing COX-2/PGE&#x2082; expression.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The antiviral effect of formononetin was determined by cytopathic effect (CPE) assay and the time course assays. The influence of formononetin for EV71 replication was determined by immunofluorescence assay, western blotting assay and qRT-PCR assay. The mechanism of the antiviral activity of formononetin was determined by western blotting assay and ELISA assay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Formononetin could reduce EV71 RNA and protein synthesis in a dose-dependent manner. The time course assays showed that formononetin displayed significant antiviral activity both before (24 or 12 h) and after (0-6 h) EV71 inoculation in SK-N-SH cells. Formononetin was also able to prevent EV71-induced cytopathic effect (CPE) and suppress the activation of ERK, p38 and JNK signal pathways. Furthermore, formononetin could suppress the EV71-induced COX-2/PGE&#x2082; expression. Also, formononetin exhibited similar antiviral activities against other members of Picornaviridae including coxsackievirus B2 (CVB2), coxsackievirus B3 (CVB3) and coxsackievirus B6 (CVB6).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Formononetin could inhibit EV71-induced COX-2 expression and PGE&#x2082; production via MAPKs pathway including ERK, p38 and JNK. Formononetin exhibited antiviral activities against some members of Picornaviridae. These findings suggest that formononetin could be a potential lead or supplement for the development of new anti-EV71 agents in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiqiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. hq_wangimb@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dajun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. zhangdajun2008@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Miao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. gemiao0708@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhuorong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. l-z-r@263.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jiandong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. jiang.jdong@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. jiang.jdong@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuhuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China. yuhuanlibj@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007529">Isoflavones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011458">Prostaglandins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>295DQC67BJ</RegistryNumber><NameOfSubstance UI="C007768">formononetin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007529" MajorTopicYN="N">Isoflavones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011458" MajorTopicYN="N">Prostaglandins E</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25890183</ArticleId><ArticleId IdType="pmc">PMC4351682</ArticleId><ArticleId IdType="doi">10.1186/s12985-015-0264-x</ArticleId><ArticleId IdType="pii">10.1186/s12985-015-0264-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778&#x2013;90. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr Opin Virol. 2012;2(2):199&#x2013;205. doi: 10.1016/j.coviro.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhu C, Bao W, Zhao K, Niu J, Yu XF, et al. Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One. 2012;7(3):e32405. doi: 10.1371/journal.pone.0032405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032405</ArticleId><ArticleId IdType="pmc">PMC3315555</ArticleId><ArticleId IdType="pubmed">22479324</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Chen LL, Huang PN, Shih SR. Neural pathogenesis of enterovirus 71 infection. Microbes Infect. 2010;12(7):505&#x2013;10. doi: 10.1016/j.micinf.2010.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2010.03.006</ArticleId><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther. 2009;7(6):735&#x2013;42. doi: 10.1586/eri.09.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.09.45</ArticleId><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung WH, Hsieh HL, Yang CM. Enterovirus 71 induces COX-2 expression via MAPKs, NF-kappaB, and AP-1 in SK-N-SH cells: Role of PGE(2) in viral replication. Cell Signal. 2010;22(2):234&#x2013;46. doi: 10.1016/j.cellsig.2009.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2009.09.018</ArticleId><ArticleId IdType="pubmed">19800403</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung WH, Hsieh HL, Lee IT, Yang CM. Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway. J Cell Biochem. 2011;112(2):559&#x2013;70. doi: 10.1002/jcb.22946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.22946</ArticleId><ArticleId IdType="pmc">PMC7166325</ArticleId><ArticleId IdType="pubmed">21268077</ArticleId></ArticleIdList></Reference><Reference><Citation>Steer SA, Corbett JA. The role and regulation of COX-2 during viral infection. Viral Immunol. 2003;16(4):447&#x2013;60. doi: 10.1089/088282403771926283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/088282403771926283</ArticleId><ArticleId IdType="pubmed">14733733</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung WH, Lee IT, Hsieh HL, Yang CM. EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF-kappaB in rat brain astrocytes. J Cell Physiol. 2010;224(2):376&#x2013;86. doi: 10.1002/jcp.22133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.22133</ArticleId><ArticleId IdType="pubmed">20333648</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Zhou F, Gu B, Ding C, Feng D, Xie F, et al. In vitro and in vivo evaluation of ribavirin and pleconarilantiviral activity against enterovirus 71 infection. Arch Virol. 2012;157(4):669&#x2013;79. doi: 10.1007/s00705-011-1222-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1222-6</ArticleId><ArticleId IdType="pubmed">22245989</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TC, Liu SC, Huang PN, Chang HY, Chern JH, Shih SR. Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants. J Biomed Sci. 2008;15(3):291&#x2013;300. doi: 10.1007/s11373-007-9228-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11373-007-9228-5</ArticleId><ArticleId IdType="pubmed">18196474</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Tao J, Yang X, Yang Z, Zhang L, Liu H, et al. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection. Biochem Biophys Res Commun. 2014;449(3):307&#x2013;12. doi: 10.1016/j.bbrc.2014.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.05.019</ArticleId><ArticleId IdType="pubmed">24845570</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu X, Wang H, Li Y, Fan W, Yu S. Antiviral activity of GuiQi polysaccharides against enterovirus 71 in vitro. Virol Sin. 2013;28(6):352&#x2013;9. doi: 10.1007/s12250-013-3376-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-013-3376-8</ArticleId><ArticleId IdType="pmc">PMC8208325</ArticleId><ArticleId IdType="pubmed">24254889</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Su H, Zhang T, Du J, Cui S, Yang F, et al. Inhibition of Enterovirus 71 replication by 7-hydroxyflavone and diisopropyl-flavon7-yl Phosphate. PLoS One. 2014;9(3):e92565. doi: 10.1371/journal.pone.0092565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092565</ArticleId><ArticleId IdType="pmc">PMC3963929</ArticleId><ArticleId IdType="pubmed">24664133</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Xiu J, Liu J, Zhang L, Li X, Xu Y, et al. Chebulagic acid, a hydrolyzable tannin, exhibited antiviral activity in vitro and in vivo against human enterovirus 71. Int J Mol Sci. 2013;14(5):9618&#x2013;27. doi: 10.3390/ijms14059618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms14059618</ArticleId><ArticleId IdType="pmc">PMC3676802</ArticleId><ArticleId IdType="pubmed">23644889</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu Y, Hou X, Peng H, Zhang L, Jiang Q, et al. Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro. PLoS One. 2013;8(9):e76007. doi: 10.1371/journal.pone.0076007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076007</ArticleId><ArticleId IdType="pmc">PMC3786884</ArticleId><ArticleId IdType="pubmed">24098754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho HY, Cheng ML, Weng SF, Leu YL, Chiu DT. Antiviral effect of epigallocatechingallate on enterovirus 71. J Agric Food Chem. 2009;57(14):6140&#x2013;7. doi: 10.1021/jf901128u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf901128u</ArticleId><ArticleId IdType="pubmed">19537794</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu QC, Wang Y, Liu YP, Zhang RQ, Li X, Su WH, et al. Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin. Eur J Pharm Sci. 2011;44(3):392&#x2013;8. doi: 10.1016/j.ejps.2011.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejps.2011.08.030</ArticleId><ArticleId IdType="pubmed">21914477</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HQ, Meng S, Li ZR, Peng ZG, Han YX, Guo SS, et al. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro. J Asian Nat Prod Res. 2013;15(4):382&#x2013;9. doi: 10.1080/10286020.2013.770737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10286020.2013.770737</ArticleId><ArticleId IdType="pubmed">23464760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhang T, Du J, et al. Anti-enterovirus 71 effects of chrysin and its phosphate ester. PLoS One. 2014;9(3):e89668. doi: 10.1371/journal.pone.0089668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089668</ArticleId><ArticleId IdType="pmc">PMC3943725</ArticleId><ArticleId IdType="pubmed">24598537</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnard DL, Hubbard VD, Smee DF, Sidwell RW, Watson KG, Tucker SP, et al. In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity. Antimicrob Agents Chemother. 2004;48(5):1766&#x2013;72. doi: 10.1128/AAC.48.5.1766-1772.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.48.5.1766-1772.2004</ArticleId><ArticleId IdType="pmc">PMC400527</ArticleId><ArticleId IdType="pubmed">15105133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai PK, Chan JY, Cheng L, Lau CP, Han SQ, Leung PC, et al. Isolation of anti-inflammatory fractions and compounds from the root of Astragalus membranaceus. Phytother Res. 2013;27(4):581&#x2013;7. doi: 10.1002/ptr.4759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.4759</ArticleId><ArticleId IdType="pubmed">22693074</ArticleId></ArticleIdList></Reference><Reference><Citation>Krenn L, Paper DH. Inhibition of angiogenesis and inflammation by an extract of red clover Trifolium pratense L.) Phytomedicine. 2009;16(12):1083&#x2013;8. doi: 10.1016/j.phymed.2009.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2009.05.017</ArticleId><ArticleId IdType="pubmed">19665361</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu H, Bai YH, Wang ST, Zhu ZM, Zhang YW. Research on antioxidant effects and estrogenic effect of formononetin from Trifolium pratense (red clover) Phytomedicine. 2009;16(4):314&#x2013;9. doi: 10.1016/j.phymed.2008.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2008.07.005</ArticleId><ArticleId IdType="pubmed">18757188</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh JE, Nam DW, Baek YH, Kang JW, Park DS, Choi DY, et al. Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways. Int Immunopharmacol. 2011;11(1):46&#x2013;54. doi: 10.1016/j.intimp.2010.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2010.10.003</ArticleId><ArticleId IdType="pubmed">20959155</ArticleId></ArticleIdList></Reference><Reference><Citation>Auyeung KK, Law PC, Ko JK. Novel anti-angiogenic effects of formononetin in human colon cancer cells and tumor xenograft. Oncol Rep. 2012;28(6):2188&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">23023137</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Zeng J, Xin M, Huang W, Chen X. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo. Horm Metab Res. 2011;43(10):681&#x2013;6. doi: 10.1055/s-0031-1286306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1286306</ArticleId><ArticleId IdType="pubmed">21932171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun T, Liu R, Cao YX. Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and -independent mechanisms. Acta Pharmacol Sin. 2011;32(8):1009&#x2013;18. doi: 10.1038/aps.2011.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2011.51</ArticleId><ArticleId IdType="pmc">PMC4002526</ArticleId><ArticleId IdType="pubmed">21818108</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Tang X, Tian J, Li C, Zhang G, Jiang W, et al. Cardioprotective effect of sulphonated formononetin on acute myocardial infarction in rats. Basic Clin Pharmacol Toxicol. 2011;108(6):390&#x2013;5. doi: 10.1111/j.1742-7843.2011.00676.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-7843.2011.00676.x</ArticleId><ArticleId IdType="pubmed">21232020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Zhou T, Zhou L, Q C, Yu Y, Yang H, et al. Formononetin protects neurons against hypoxia-induced cytotoxicity through upregulation of ADAM10 and sA&#x3b2;PP&#x3b1;. J Alzheimers Dis. 2012;28(4):795&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">22085862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor GS, O&#x2019;Rourke DM. Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches. Cancer Biol Ther. 2003;2(4):330&#x2013;42. doi: 10.4161/cbt.2.4.507.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cbt.2.4.507</ArticleId><ArticleId IdType="pubmed">14508101</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtsu H, Dempsey PJ, Eguchi S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol. 2006;291(1):C1&#x2013;10. doi: 10.1152/ajpcell.00620.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00620.2005</ArticleId><ArticleId IdType="pubmed">16769815</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer B, Marinov M, Arcaro A. Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far? Cancer Treat Rev. 2007;33(4):391&#x2013;406. doi: 10.1016/j.ctrv.2007.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ctrv.2007.01.006</ArticleId><ArticleId IdType="pubmed">17368733</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodemann HP, Dittmann K, Toulany M. Radiation-induced EGFR-signaling and control of DNA-damage repair. Int J Radiat Biol. 2007;83(11&#x2013;12):781&#x2013;91. doi: 10.1080/09553000701769970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09553000701769970</ArticleId><ArticleId IdType="pubmed">18058366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei YH, Fang W, Wan ZY, Wang KM, Yang QY, Cai XF, et al. Antiviral effects against EV71 of pimprinine and its derivatives isolated from Streptomyces sp. Virol J. 2014;11:195. doi: 10.1186/s12985-014-0195-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-014-0195-y</ArticleId><ArticleId IdType="pmc">PMC4253628</ArticleId><ArticleId IdType="pubmed">25410379</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wang C, Xu L, Wang W, Yang G, Tan RX, et al. A laboratory evaluation of medicinal herbs used in china for the treatment of hand, foot, and mouth disease. Evid Based Complement Alternat Med. 2013;2013:504563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3608275</ArticleId><ArticleId IdType="pubmed">23554831</ArticleId></ArticleIdList></Reference><Reference><Citation>Clercq ED. Highlights in Antiviral Drug Research: Antivirals at the Horizon, Med. Res. Rev., 00, No. 0, 1&#x2013;34, 2012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7168470</ArticleId><ArticleId IdType="pubmed">22553111</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut HJ, De Palma AM, Neyts J. Combating enterovirus replication: state-of-the-art on antiviral research. Biochem Pharmacol. 2012;83(2):185&#x2013;92. doi: 10.1016/j.bcp.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2011.08.016</ArticleId><ArticleId IdType="pubmed">21889497</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Li ML, Huang PN, Chien KY, Horng JT, Shih SR. Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5&#x2019; untranslated region and participates in virus replication. J Gen Virol. 2008;89(Pt 10):2540&#x2013;9. doi: 10.1099/vir.0.2008/003673-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/003673-0</ArticleId><ArticleId IdType="pubmed">18796723</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, He Y, Chen Y, Kung HF, He ML. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir Ther. 2011;16(1):51&#x2013;8. doi: 10.3851/IMP1720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP1720</ArticleId><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>